A Study of Induction Dosing With PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus in Treatment-Naive Patients With Chronic Hepatitis C.

This study is ongoing, but not recruiting participants.

Study NCT00394277 Information provided by Hoffmann-La Roche

First Received: October 30, 2006 Last Updated: September 16, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Hepatitis C, Chronic

Additional conditions recognized in this trial

Hepatitis
Hepatitis C
Hepatitis, Chronic

More general conditions related to this trial

Interventions listed in this trial

Copegus

Additional drug interventions recognized in this trial

More general drug interventions related to this trial

Sponsors listed in this trial

Hoffmann-La Roche